Sherbrooke International Life Sciences Summit (SILS)
Dr. Nadine Beauger, Vice-President, Scientific Liaison at IRICoR will participate in the upcoming SILS meeting to be held September 26–27, 2013. This major event is a great opportunity to identify development perspectives in Life Sciences, a constantly evolving sector.
If you would like to arrange a one-on-one meeting with IRICoR during the conference to learn more about our business model and our portfolio, please contact Nadine Beauger, at: email@example.com .
About Sherbrooke International Life Sciences Summit
Sherbrooke International Life Sciences Summit, September 26th and 27th 2013, is a not-to-be-missed event to get an overview of the Life Sciences industry and identify development perspectives. Organized by Sherbrooke Innopole, in partnership with Rx&D and MEDEC, this event will bring together participants from the pharmaceutical and medical technologies industries – large and small businesses –, investors, and representatives from governments, universities, and the economic development sector. A unique chance to boost your international business network in this dynamic sector! To learn more about Sherbrooke International Life Sciences Summit, please visit: http://sils-sherbrooke.com/en/home/
About IRICoR | Institute for Research in Immunology and Cancer – Commercialization of Research
IRICoR is Université de Montréal’s non-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate from IRIC/Université de Montréal and collaborating centres. IRICoR, as a Center of Excellence in Commercialization and Research, invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially-promising projects. For more information about IRICoR, please visit: www.iricor.ca.
Nadine Beauger Ph.D., MBA
Vice-President, Scientific Liaison
T +1 514 343.6111 ext 0315